CN1323608A - Xinnaotong capsule for treating blood vessel of heart and brain - Google Patents
Xinnaotong capsule for treating blood vessel of heart and brain Download PDFInfo
- Publication number
- CN1323608A CN1323608A CN01100440A CN01100440A CN1323608A CN 1323608 A CN1323608 A CN 1323608A CN 01100440 A CN01100440 A CN 01100440A CN 01100440 A CN01100440 A CN 01100440A CN 1323608 A CN1323608 A CN 1323608A
- Authority
- CN
- China
- Prior art keywords
- capsule
- radix
- heart
- brain
- blood vessel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a new Tibetan drug ---"shining pearl" heart-brain through capsule. The drug is made from 9 medicinal materials by using 3 methods of extraction. (1) astragalus root, earth worm, sappan wood and achyranthes root are extracted with water 3 times then the extracted liquids are merged, filtered, concentrated, dried and crushed into powder. (2) chuanxiong rhizome, angelica, gadol are reflux extracted 3 times by 70% alcohol, then merge these extracted liquids, reduced pressure to cover alcohol, concentrated in into paste dried and crushed into powder. (3) arisaema with bile is dried by fire and mixed with saffron, then crushed into powder. Mixing above three powders according to ratio, then adding auxiliary materials to the mixture and packed into capsule. The capsule provides efficiency of promoting blood circulation to dispel blood stasis, soothing the nerves, regulation of qi and the blood, regularizing and balancing the functions of human body. It applies to prevention and cure of coronary sclerosis, coronary heart disease, anemic heart disease, as well as high blood pressure, cerebral thrombosis, sequela of apoplexy. It has features of easy to use, taking effect quickly, high curative ratio and unease recurring. It could relieve thoroughly harassement from high blood pressure and heart disease caused by disease of heart and brain blood vessel.
Description
The present invention relates to a kind of Tibetan medicine new drug for the treatment of cardiovascular and cerebrovascular disease---brilliant megarchidium nicergoline capsule, add up according to World Health Organization (WHO), annual about 1,200 ten thousand people die from cardiovascular disease, account for 1/4 of the annual death toll in the whole world, and the height of the incidence rate of cerebrovascular disease is also very surprising, China's onset state and international statistics basically identical, the sickness rate of cardiovascular and cerebrovascular disease also accounts for first of spectrum of disease, therefore, press in the society and a kind ofly can treat this type of disease and instant effect, cure rate height and be difficult for the specific drug of recurrence.
The object of the present invention is to provide a kind of new drug that can treat cardiovascular and cerebrovascular disease, and instant effect, cure rate height, be difficult for the brilliant megarchidium nicergoline capsule of recurrence.
The object of the present invention is achieved like this: the Radix Astragali, Pheretima, Lignum Sappan, Huai Niutengshui carry three times, merge three times extracting solution, filter, concentrate, dry, pulverize; Rhizoma Chuanxiong, Radix Angelicae Sinensis, Radix Rhodiolae are condensed into cream, oven dry, pulverizing with 70% alcohol reflux three times, three extracting solution of merging, decompression recycling ethanol.Arisaema Cum Bile oven dry back is mixed, is pulverized with Stigma Croci, with three kinds of medicated powder mixing in proportion, adds adjuvant, fill capsule, it is characterized in that its raw materials in part by weight is:
Stigma Croci 4-6g
Radix Rhodiolae 150-250g
Lignum Sappan 100-200g
Radix Angelicae Sinensis 100-300g
Arisaema Cum Bile 50-150g
Rhizoma Chuanxiong 150-250g
Radix Astragali 200-400g
Pheretima 100-200g
Bosom Radix Achyranthis Bidentatae 100-200g.
Xinnaotong capsule for treating blood vessel of heart and brain of the present invention, its feature are that also its raw materials in part by weight is preferably:
Stigma Croci 5.0g
Radix Rhodiolae 200.0g
Lignum Sappan 150.0g
Radix Angelicae Sinensis 200.0g
Arisaema Cum Bile 100.0g
Rhizoma Chuanxiong 200.0g
Radix Astragali 300.0g
Pheretima 150.0g
Bosom Radix Achyranthis Bidentatae 150.0g.
Xinnaotong capsule for treating blood vessel of heart and brain new drug of the present invention has blood circulation promoting and blood stasis dispelling, and tranquilizing mind, QI and blood regulating are in harmonious proportion grand, red crust, Baconic's equilibrium function; Be applicable to that comprehensive wooden brucellosis spreads to heart (coronary atherosclerosis, coronary heart disease, ischemic heart desease, angina pectoris) and spreads to head (hypertension, cerebral thrombosis, apoplexy sequela) treatment of diseases and prevention.Characteristics with instant effect, cure rate height, difficult recurrence.
Below in conjunction with embodiment the present invention is described, the scheme of embodiment described here, do not limit the present invention, one of skill in the art can make improvements and change according to spirit of the present invention, described these improvement and variation all should be considered as in the scope of the present invention, and scope and spirit of the present invention are limited by claim.
Embodiment
Get: Stigma Croci 5.0g
Radix Rhodiolae 200.0g
Lignum Sappan 150.0g
Radix Angelicae Sinensis 200.0g
Arisaema Cum Bile 100.0g
Rhizoma Chuanxiong 200.0g
Radix Astragali 300.0g
Pheretima 150.0g
Bosom Radix Achyranthis Bidentatae 150.0g.
And, adopting three kinds of modes to extract with this product 9 flavor medical materials, the Radix Astragali, Pheretima, Lignum Sappan, Huai Niutengshui carry three times in the side, merge three times extracting solution, filter, concentrate, dry, pulverize; Rhizoma Chuanxiong, Radix Angelicae Sinensis, Radix Rhodiolae 70% alcohol reflux three times, three extracting solution of merging, decompression recycling ethanol are condensed into cream, oven dry, pulverizing; Arisaema Cum Bile oven dry back is mixed, is pulverized with Stigma Croci, with three kinds of medicated powder mixing in proportion, adds adjuvant, fill becomes 1000 capsules, promptly gets product of the present invention.
Claims (3)
1, a kind of preparation method of Xinnaotong capsule for treating blood vessel of heart and brain: get this product 9 flavor medical materials, adopt three kinds of modes to extract, the Radix Astragali, Pheretima, Lignum Sappan, Huai Niutengshui carry three times in the side, merge three times extracting solution, filter, concentrate, dry, pulverize; Rhizoma Chuanxiong, Radix Angelicae Sinensis, Radix Rhodiolae 70% alcohol reflux three times, three extracting solution of merging, decompression recycling ethanol are condensed into cream, oven dry, pulverizing; Arisaema Cum Bile oven dry back is mixed, is pulverized with Stigma Croci, with three kinds of medicated powder mixing in proportion, adds adjuvant, fill capsule, it is characterized in that its raw materials in part by weight is:
Stigma Croci 4-6g
Radix Rhodiolae 150-250g
Lignum Sappan 100-200g
Radix Angelicae Sinensis 100-300g
Arisaema Cum Bile 50-150g
Rhizoma Chuanxiong 150-250g
Radix Astragali 200-400g
Pheretima 100-200g
Bosom Radix Achyranthis Bidentatae 100-200g.
2, according to the Xinnaotong capsule for treating blood vessel of heart and brain of claim 1, its feature is that also its raw materials in part by weight is preferably:
Stigma Croci 5.0g
Radix Rhodiolae 200.0g
Lignum Sappan 150.0g
Radix Angelicae Sinensis 200.0g
Arisaema Cum Bile 100.0g
Rhizoma Chuanxiong 200.0g
Radix Astragali 300.0g
Pheretima 150.0g
Bosom Radix Achyranthis Bidentatae 150.0g.
3, according to claim 1 or the 2 a kind of new drugs that prepare.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN01100440A CN1131048C (en) | 2001-01-11 | 2001-01-11 | Xinnaotong capsule for treating blood vessel of heart and brain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN01100440A CN1131048C (en) | 2001-01-11 | 2001-01-11 | Xinnaotong capsule for treating blood vessel of heart and brain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1323608A true CN1323608A (en) | 2001-11-28 |
| CN1131048C CN1131048C (en) | 2003-12-17 |
Family
ID=4651592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN01100440A Expired - Lifetime CN1131048C (en) | 2001-01-11 | 2001-01-11 | Xinnaotong capsule for treating blood vessel of heart and brain |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1131048C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1931218B (en) * | 2005-09-14 | 2010-04-14 | 山东轩竹医药科技有限公司 | Medicine composition of ligustrazine and rhodiola root |
| CN104825682A (en) * | 2015-04-22 | 2015-08-12 | 李学香 | Traditional Chinese medicine for treatment of coronary heart disease angina pectoris |
| CN109288939A (en) * | 2018-11-21 | 2019-02-01 | 青海晶珠藏药高新技术产业股份有限公司 | A kind of drug and preparation method thereof for treating cardiovascular and cerebrovascular disease |
-
2001
- 2001-01-11 CN CN01100440A patent/CN1131048C/en not_active Expired - Lifetime
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1931218B (en) * | 2005-09-14 | 2010-04-14 | 山东轩竹医药科技有限公司 | Medicine composition of ligustrazine and rhodiola root |
| CN104825682A (en) * | 2015-04-22 | 2015-08-12 | 李学香 | Traditional Chinese medicine for treatment of coronary heart disease angina pectoris |
| CN109288939A (en) * | 2018-11-21 | 2019-02-01 | 青海晶珠藏药高新技术产业股份有限公司 | A kind of drug and preparation method thereof for treating cardiovascular and cerebrovascular disease |
| CN114306485A (en) * | 2018-11-21 | 2022-04-12 | 青海晶珠藏药高新技术产业股份有限公司 | Composition and medicine for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1131048C (en) | 2003-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1262267C (en) | Speckle removing and whitening traditional medicinal healthy product and its preparation | |
| CN1176814A (en) | Oral liquor for preventing and curing cerebrovascular disease | |
| CN101953918A (en) | Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases | |
| CN101991814A (en) | Preparation with functions of expelling wind, reducing phlegm, promoting blood circulation and removing obstruction from channels and preparation method | |
| CN1263503C (en) | 'Changyuan' capsule and preparing techniue | |
| CN102100873B (en) | Chinese patent medicine for treating heart cerebrovascular diseases and preparation method thereof | |
| CN1323608A (en) | Xinnaotong capsule for treating blood vessel of heart and brain | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN1364512A (en) | Defatting and poison expelling capsule | |
| CN101375978B (en) | Medicinal composition for lowering blood fat | |
| CN1166397C (en) | Medicine for treating cardiovascular and cerebrovascular system disease, apoplectic sequel | |
| CN1180821C (en) | Medicine for treating cerebral thrombus and its prepn | |
| CN1745795A (en) | Medicine for preventing coronary heart disease and its preparation | |
| CN1025774C (en) | Special "shanhaidan" and its production method | |
| CN1323607A (en) | Fast-acting heart disease curing drop pill | |
| CN101549057A (en) | Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same | |
| CN1124143C (en) | Pregnancy promoting medicine for treating hyperprolactinemia sterility and its preparation | |
| CN110339293A (en) | A kind of arteries and veins gel resin capsule formula and preparation process | |
| CN1768803A (en) | Medicine for treating hypertension and its preparing process | |
| CN115554358B (en) | Traditional Chinese medicine composition and traditional Chinese medicine preparation for improving depression, and preparation method and application thereof | |
| CN1559523A (en) | Naodesheng soft capsule and its preparation method | |
| CN1131049C (en) | Proriasis treating Yinxieling capsule | |
| CN1207042C (en) | Sleepless treating medicine and its preparation | |
| CN105395794A (en) | Application of traditional Chinese medicine to anti-oxidation medicine preparation | |
| CN115177664A (en) | Traditional Chinese medicine composition, traditional Chinese medicine preparation and traditional Chinese medicine product for treating cardiovascular and cerebrovascular diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Qinghai jingzhuzangyao high-tech industry Limited by Share Ltd Assignor: Li Fangrui Contract fulfillment period: 2007.11.20 to 2013.11.20 Contract record no.: 2009110000250 Denomination of invention: Medicine for treating angiocardiopathy and cerebrovascular disease and its preparing method Granted publication date: 20031217 License type: Exclusive license Record date: 20091021 |
|
| LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2007.11.20 TO 2013.11.20; CHANGE OF CONTRACT Name of requester: QINGHAI JINGZHU TIBETAN MEDICINE HIGH-TECH INDUSTR Effective date: 20091021 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20151111 Address after: 810008 Qinghai biological science and Technology Industrial Park, Chengbei District, Qinghai, 36, No. three, Xining Road Patentee after: Qinghai jingzhuzangyao high-tech industry Limited by Share Ltd Address before: 100062 Beijing city Chong Street No. 5-4 new world Taihua apartment block A room 510 Patentee before: Li Fangrui |
|
| CX01 | Expiry of patent term |
Granted publication date: 20031217 |
|
| CX01 | Expiry of patent term |